ml 9 has been researched along with fura-2-am in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, H; Kakizawa, H; Ohno, R; Takahashi, R; Watanabe, H; Zhang, XX | 1 |
| Hayashi, H; Honjo, H; Ito, S; Katoh, H; Kodama, I; Kume, H; Shimokata, K | 1 |
2 other study(ies) available for ml 9 and fura-2-am
| Article | Year |
|---|---|
Roles of inhibitors of myosin light chain kinase and tyrosine kinase on cation influx in agonist-stimulated endothelial cells.
Topics: Animals; Aorta; Azepines; Bradykinin; Calcium; Cations, Divalent; Cell Membrane; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Genistein; Isoflavones; Kinetics; Manganese; Myosin-Light-Chain Kinase; Protein-Tyrosine Kinases; Swine; Thapsigargin | 1997 |
ML-9, a myosin light chain kinase inhibitor, reduces intracellular Ca2+ concentration in guinea pig trachealis.
Topics: Androstadienes; Animals; Azepines; Calcium; Calcium Channel Blockers; Fura-2; Guinea Pigs; Imidazoles; In Vitro Techniques; Isometric Contraction; Male; Methacholine Chloride; Muscarinic Agonists; Muscle, Smooth; Myosin-Light-Chain Kinase; Potassium; Potassium Channel Blockers; Thapsigargin; Trachea; Wortmannin | 2004 |